Table 2.
The frequency and proportion of adverse events during anti-tuberculosis treatment.
| AE Groups | No. | % |
|---|---|---|
| Liver injury * | 205 | 36.94 |
| Gastrointestinal reactions * | 132 | 23.78 |
| Renal impairment | 28 | 5.05 |
| Blood system damage | 18 | 3.24 |
| Auditory nerve damage | 4 | 0.72 |
| Optic nerve damage | 15 | 2.70 |
| Drug allergy | 69 | 12.43 |
| Neuropsychiatric symptoms | 37 | 6.67 |
| Joints/Muscle pain | 35 | 6.31 |
| Electrolyte abnormalities | 1 | 0.18 |
| Thyroid dysfunction | 0 | 0 |
| Other adverse events | 11 | 1.98 |
Note: * There were 11 patients overlapping between these two groups, and the liver function test values of patients with liver injuries and patients with gastrointestinal reactions were described in Supplementary Material 4.